Skip to main content
Log in

Impact of the global on patient perceivable change in an asthma specific QOL questionnaire

  • Research Papers
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

One method of defining clinically meaningful changes in quality of life domain scores is ‘anchoring’, that is, relating changes in domain scores to more easily understood changes on a global question. Although this methodology has been used to assess changes in domain scores in clinical trials, the choice of global question has not undergone much scrutiny. This study examines the impact of two global questions on the definition of clinically meaningful changes in an asthma specific quality of life (ASQOL) questionnaire. We tracked 343 patients with mild to moderate asthma symptoms in a placebo controlled clinical trial. The patients responded to the ASQOL questionnaire, and answered two global questions; one assessing how well their asthma is controlled, and the other assessing the change in their asthma since the start of the study. Changes in each domain of the ASQOL questionnaire were related to each global question. Since each global question led to different definitions of what constituted meaningful change, we concluded that the wording of the global question can affect the definition of meaningful change in the ASQOL domain scores. Thus, when identifying meaningful changes, it is important to state the global question so that the context of the meaningful change is correctly understood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lydick E and Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993: 2: 221–226.

    Google Scholar 

  2. Deyo RA and Patrick DL. The significance of treatment effects: The clinical perspective. Med Care 1995; 33 No. 4: AS286-AS291.

    Google Scholar 

  3. Minutes from Zileuton FDA Advisory Committee Meeting, held on April 10, 1995.

  4. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax 1992; 47(2): 76–83.

    Google Scholar 

  5. Juniper EF, Guyatt GH, Ferrie PJ, and Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–838.

    Google Scholar 

  6. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidem 1994; 47(1): 81–87.

    Google Scholar 

  7. Rowe BH, and Oxmen AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Resp Dis 1993; 148: 675–681.

    Google Scholar 

  8. Jaeschke R, singer J, Guyatt GH. Measurement of health status. Control Clin Trials 1989; 10: 407–415.

    Google Scholar 

  9. Spitzer RL, Cohen J, Fleiss JL, Endicott J. Quantification of agreement in psychiatric diagnosis. Arch Gen Psychiatry 1967; 17: 83–87.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Sponsored by Merck Research Laboratories, West Point, PA, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barber, B.L., Santanello, N.C. & Epstein, R.S. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Qual Life Res 5, 117–122 (1996). https://doi.org/10.1007/BF00435976

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00435976

Key words

Navigation